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Abstract
Background: Preclinical evidence suggests that the anthocyanins, which
comprise a subclass of dietary flavonoids providing the purple and red pig-
mentation in plant-based foods, may have a beneficial impact on cognitive
outcomes.
Methods: A systematic review was conducted to identify the published liter-
ature on food-based anthocyanin consumption and cognitive outcomes in
human intervention trials. The literature search followed PRISMA guidelines
and included six databases, as well as additional hand searching.
Results: Seven studies were included in this review, comprising acute trials
(n = 4) and longer-term (n = 3) interventions that assessed multiple cogni-
tive outcomes in children, adults and older adults with cognitive impair-
ment. Six of seven studies reported improvements in either a single, or
multiple, cognitive outcomes, including verbal learning and memory, after
anthocyanin-rich food consumption. As a result of methodological limita-
tions and the large clinical and methodological diversity of the studies, the
pooling of data for quantitative analysis was not feasible.
Conclusions: The impact of food-based anthocyanin consumption on both
acute and long-term cognition appears promising. However, adequately
powered studies that include sensitive cognitive tasks are needed to confirm
these findings and allow the translation of research into dietary messages.
Introduction
The rapidly ageing population has led to a major pro-
jected increase in the prevalence of neurodegenerative
diseases such as dementia (1), which has resulted in
intense research interest regarding the role of diet in
neuroprotection. Dietary approaches are especially con-
sidered to comprise safe and effective methods for the
prevention of cognitive disorders and the maintenance
of cognitive function. The consumption of dietary
flavonoids was shown to both enhance cognitive
function (2) and prevent age-related cognitive decline in
older adults (3). The neuroprotective effects of flavo-
noids have been well-documented (4–8), although most
of the research has focused on animal models, limiting
translation to humans who utilise more complex cogni-
tive domains, such as executive functioning. Because of
their strong antioxidant potential (9), it has been
hypothesised that flavonoids limit neurodegeneration by
reducing neuro-inflammation and protecting the cellular
architecture in the brain (10). Flavonoids may also con-
tribute to improved cognitive function by increasing the
number and strength of neuronal signals (11) via
increased brain blood flow (7) and an ability to initiate
neurogenesis (5) in areas of the brain associated with
learning and memory. A large proportion of this
research has specifically highlighted the benefits of
anthocyanin-rich foods (12–15).
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Anthocyanins are a subclass of dietary flavonoids (i.e.
different from proanthocyanidins, which are polymers of
flavanols), which provide the purple, red and blue pig-
mentation in plant-based foods (16). Typical food sources
of anthocyanins are fruits such as apples, grapes, plums;
berries such as strawberries, blueberries and blackberries;
vegetables such as red cabbage, red onion and eggplant;
and beverages such as red wine and red grape juice (17).
Approximately 640 individual anthocyanins have been
identified to date (18); however, anthocyanins naturally
occur most ubiquitously in six common aglycones
(pelargonidin, cyanidin, delphinidin, peonidin, petunidin,
malvidin) in various glycosylated and acylated forms (18).
Anthocyanins are unique among flavonoids as a result of
their ability to reversibly change their structures in
response to changing pH values, from the stable red to
orange coloured flavylium cation at pH < 2 to the
colourless and less stable carbinol and chalcone forms at
higher or neutral pH (18–20). This unique feature may
have a an impact on their stability and binding ability
(e.g. to enzymes) throughout the gut, which has a dra-
matically changing pH environment (‘acid’ stomach to
‘neutral’ intestine).
The metabolism and absorption of anthocyanins has
been documented previously (21). Briefly, food-based
anthocyanins are consumed and are either quickly
absorbed as intact molecules via the stomach, or after
extensive metabolism in the small and large intestine or
the colon, to enter the circulation as metabolites such as
phenolic acids (21). In previous animal and human studies,
only very low amounts of intact (non-metabolised) antho-
cyanin glycosides could be detected in plasma and urine
after ingestion of pure anthocyanin compounds and/or
anthocyanin-rich food and beverages; 15 animal and 17
human bioavailability studies were comprehensively
reviewed by Pojer et al. (19). However, recent human stud-
ies have clearly demonstrated that dietary anthocyanins
undergo intensive metabolism after consumption and
that those metabolites are the main transport forms
in vivo (22–25). For example, thirty-two anthocyanin-
derived metabolites could be detected in the urine, serum
and faeces of eight healthy volunteers after the consump-
tion of 500 mg of 13C-labelled cyanidin-3-glucoside (23).
In another study published by Ludwig et al. (22), 17
metabolites were quantified in urine collected from nine
volunteers after the consumption of 300 g of blended
raspberries (22). Previously, the bioavailability of antho-
cyanins was considered to be very low (urinary recoveries
<2% of intake in most studies), although it is now esti-
mated as being at least 15% if detectable in vivo metabo-
lites are also taken into account (22).
The main biological activity of anthocyanins in vivo
was assumed to be their antioxidant capacity and
protection against lipid peroxidation (26). However, recent
studies have identified more complex molecular effects of
anthocyanins on signalling pathways in cells that may
play a significant role in their protection against chronic
diseases (19,26,27). Modulation of neuronal functions by
anthocyanin-rich food has been reported in several ani-
mal studies (19). It is suggested that these neuroprotective
effects (e.g. improved memory, learning, cognitive and
motor functions) by anthocyanins (and/or their in vivo
metabolites) are mediated via inhibition/suppression of
interleukin-1b, tumor necrosis factor-a and nuclear factor
kappa B. The modulatory effects of anthocyanins on
important structural and synaptic plasticity markers have
also been reported. Acute improvements in cognition
after consuming anthocyanin-rich foods have been associ-
ated with increased cerebral blood flow (1–2 h and 6 h
after consuming anthocyanin-rich blueberries) and
improvements in endothelium-dependent vasodilation (as
assessed by flow-mediated dilatation) (28,29).
A body of evidence concerning the benefits of antho-
cyanin consumption in human health, including protec-
tive effects against age-related neurodegeneration and
cognitive decline, has accumulated over the recent years
(16,19). Animal studies have provided evidence that
anthocyanin-rich food consumption can improve several
cognitive functions, including long-term memory (30),
spatial-working memory (31) and object-recognition
memory (32). In addition, improvements in motor per-
formance
(i.e. balance and coordination) have been documented
after receiving an anthocyanin-rich blueberry supple-
mented diet in an animal model (14). Intact (non-meta-
bolised) anthocyanins were detected in the brains of rats
as soon as 10 min after their consumption, and these
concentrations were found to be correlated with
improvements in learning and memory tasks (13). Of
particular interest, supplementation of the diet with
anthocyanin-rich fruits, such as blueberries and strawber-
ries, was shown to not only maintain, but also reverse
age-related cognitive decline in animal models (11,33,34).
A large epidemiological study of 16 010 older women
enrolled in the Nurses’ Health Study reported significant
associations between anthocyanin-rich blueberry and
strawberry consumption and the maintenance of cognitive
function (a composite score of six cognitive tests, includ-
ing various measures of memory) over 4 years (35). It was
reported that those individuals who consumed the highest
amount of berries had delayed cognitive ageing by up to
2.5 years compared to those who ate the least (35).
Despite their known health benefits, anthocyanins are
often overlooked in human intervention trials that inves-
tigate the impact of overall flavonoid intake on cognitive
outcomes (36). In a 2009 systematic review of human
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intervention trials assessing the impact of flavonoids on
cognitive outcomes (36), no studies related to antho-
cyanins were included.
There has been increasing interest in other areas of
anthocyanin research, with a 15-fold rise in the number
of published papers between 1990 and 2013 including the
word ‘anthocyanin’ in their title and abstract (37). Impor-
tant advances in an increased understanding of the
bioavailability and metabolism of anthocyanins (e.g. bio-
transformation by the gut microbiota), coupled with a
greater focus on the role of plant foods in brain health
(e.g. neuroprotective activities), warrant a targeted review
aiming to summarise the evidence to date of human trials
on anthocyanins and cognitive function.
Materials and methods
A systematic review of the literature was performed aim-
ing to summarise the published literature on the effects
of food-based anthocyanin consumption on cognitive
function in human trials. The review also aimed to iden-
tify gaps in the literature and to consider the implications
for future study designs. The search was conducted using
methodology outlined in the PRISMA statement (38),
according to the search strategy outlined below.
Types of studies
Studies were eligible for inclusion in this review if they:
• were randomised or nonrandomised controlled trials;
cross-over trials (excluding case studies and observational
studies)
• examined humans (any age, sex);
• administered a naturally occurring anthocyanin con-
taining food or beverage (the anthocyanin content of the
food needed to be objectively measured; foods fortified
with additional anthocyanin were excluded);
• measured change in cognitive function using single
or multiple instruments that had previously been vali-
dated in a similar population; and
• had full text available.
Only studies written in the English language were con-
sidered because of a lack of translational resources,
although studies from any country were eligible if they
met the rest of the inclusion criteria.
Search terms
The following search terms were developed:
• Anthocyan* and/or
• Flavonoid* and
• Cognit* and/or
• Memory
The * indicates a truncation, to ensure all variations of
the search terms were included.
Databases
A three-stage search was conducted. First, a search of the
following databases (abstract, title and keywords) was
performed using the search terms using the Boolean
terms AND/OR as appropriate:
• Scopus (1960 to Oct 2015)
• Medline (1960 to Oct 2015)
• CIHNAL (1960 to Oct 2015)
• Psychology and Behavioural Sciences Collection
(1960 to October 2015)
• PsychInfo (1860 to October 2015)
• Web of Science (1965 to October 2015)
Second, hand searching of the reference list of identi-
fied studies was conducted. Third, an internet search was
performed to identify any published studies outside the
realms of the selected databases. The records were
exported from the databases and managed in ENDNOTE X4
(Thomson Reuters, New York, NY, USA). After screening
and selection of studies according to the inclusion criteria
(Fig. 1), relevant summary data were extracted into a
template made for this purpose, including the study
design, intervention, dose, methods and results.
Results
The search returned 1684 articles and four other potential
studies were identified through hand-sorting of reference
lists. After duplicates were removed and the titles
screened, 35 potential studies were identified. After
screening abstracts, a further 25 were excluded and, after
reading the full text articles of 10 studies, a further three
were excluded according to the inclusion/exclusion crite-
ria (Table 1), leaving seven papers in the final review
(Fig. 1).
Description of studies
Statistical pooling of the data from the seven studies con-
sidered eligible for the review (39–45) was not possible
because of the large clinical and methodological diversity
of the studies. This heterogeneity resulted from variability
in the characteristics of the participants and type of
intervention (including food sources and dose of
anthocyanins), varying study designs and study duration,
as well as differences in choice of cognitive outcomes.
The findings are therefore presented in narrative form.
The characteristics and relevant information of each
study are described in Table 2. Publication dates ranged
from 2010 to 2015. Of the seven included studies,
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three were randomised, double-blind, placebo-controlled
studies (39,40) that assessed the daily consumption of
anthocyanin-rich fruit juices on cognitive outcomes. The
remaining four were placebo-controlled cross-over trials,
either randomised (n = 2) (42,44) or nonrandomised
(n = 2) (41,45) that assessed the acute impact of antho-
cyanin rich fruit juices on cognitive outcomes. Two stud-
ies investigated older adults with mild cognitive
impairment (39,40), one study included older adults
with dementia (43), one study was conducted in young,
healthy adults (42), one study included a combination
of older adults with and without dementia as well as
healthy younger adults (44), and two studies were under-
taken in children (41,45). The studies were undertaken
in New Zealand (42), the USA (39,40), the UK (41,45) and
Australia (43,44).
Description of the interventions
In all seven studies, the vehicle for anthocyanin adminis-
tration was a beverage. Four studies utilised a preformu-
lated juice (39,40,43,44), one study (42) utilised a juice
processed from fresh fruit (150 g of fruit yielded approxi-
mately 140 mL of juice), two studies used a powdered
freeze-dried fruit made up with water (42) or cordial (45)
and one study (41) blended fresh fruit into a smoothie.
Two studies based the beverage serving size on the body
weight of each participant (39,40) providing between 6 and
9 mL of juice kg1 body weight of juice (providing
between 428 and 598 mg anthocyanins day1 divided
over three servings). One study (42) altered the serving
sizes of the juice to consistently deliver a mean (SD) of
525 (5) mg of polyphenols per 60 kg of bodyweight per
participant. Four studies (41,43–45) administered a standard
serving size to each participant, regardless of body size,
providing total anthocyanins of between 55 mg (44) and
253 mg day1 (45).
Outcome assessment
Cognitive outcomes were measured using valid, refer-
enced instruments in all studies. Four studies measured
acute change in cognition (41,42,44,45), whereas the other
three studies measured longer-term change in cognition
of between 12 and 16 weeks (39,40,43). Detailed results,
including significant effects, are reported below.
Longer-term anthocyanin supplementation and cognition
Two of the longer-term studies evaluated verbal learning
and memory in older adults with mild cognitive impair-
ment (39,40) using the California Verbal Learning Test and
one study measured the same outcome using the Rey
Auditory Verbal Learning Test (RAVLT) (43). One study
Records identified through database 
searching (n = 1684)
Additional records identified through other 
sources (n = 4)
Records after duplicates removed 
(n = 1229)
Titles screened 
(n = 1229)
Abstracts assessed for 
eligibility 
(n = 35)
Articles excluded 
(n = 25)
Studies included in qualitative 
synthesis (n = 7)
Full text accessed 
(n = 10)
Articles excluded
(n = 3)
Records excluded 
(n = 1194)
Figure 1 PRISMA flowchart for the search and study
selection process of included and excluded studies.
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measured change in explicit episodic memory using the
Paired Associate Learning Test (40) and two studies
assessed change in mood using the Geriatric Depression
Scale (39,43). One study measured several other cognitive
domains, including working memory (self-ordered point-
ing task), semantic memory (the Boston naming test),
executive function (trail making test, category and letter
verbal fluency) and short-term memory (digit span back-
wards task) (43). One study (39) measured brain activity
objectively, using functional magnetic resonance imaging
(fMRI) brain imaging, which indicates stimulation and
activity in specific regions of the brain.
Krikorian et al. (39) reported that, after 16 weeks of
supplementation with concord grape juice, there was no
between-group difference for performance on the CVLT
learning task, although there was a reduction in inter-
ference on the CVLT memory task compared to base-
line (P = 0.04). There was a nonsignificant effect on
mood. Analysis of the fMRI brain analysis indicated
that there was greater activation in the anterior and
posterior regions of the brain for the intervention group
only (39). In another study, the same research team
of Krikorian et al. (40) reported significant improve-
ments on the verbal paired associate learning task
(P = 0.009) after 12 weeks of supplementation with
blueberry juice. However, both of these studies had
small sample sizes of only 10 in the Concord grape
juice intervention arm (39) and nine in the blueberry
juice intervention arm (40).
Kent et al. (43) conducted a larger trial (n = 21 per
group) in older adults with mild–moderate dementia and
reported that, after 12 weeks of supplementation with
cherry juice (138 mg day1), there were significant
improvements in verbal fluency (P = 0.014), short-term
memory (RAVLT) (P = 0.014) and long-term memory
(RAVLT delayed) (P ≤ 0.001).
Acute anthocyanin supplementation and cognition
The four acute feeding studies evaluated change in cogni-
tion using a variety of tests: the digital vigilance test
(a measure of attention) (42), the rapid visual information
processing test (attention and working memory) (42), the
go-no-go test (response inhibition) (41,45), an objective
location task (spatial memory) (41), a visual-n back test
(attention and short-term memory) (41), a task switching
test (higher executive function) (44), a pattern and letter
comparison task (speed of processing) (44), a picture
matching task (processing and response interference) (45)
and the auditory verbal learning task (verbal learning and
memory) (45). Two studies used the Stroop test to mea-
sure attention and inhibition (41,42) and the RAVLT to
measure verbal learning and memory (41,44).
Watson et al. (42) compared three conditions (placebo
versus powdered blackcurrant extract with 7.7 mg antho-
cyanins kg1 versus blackcurrant juice with 8 mg kg1,
based on body weight) on acute cognition in 36 young
adults by administering tasks seven consecutive times
over 65 min after consumption of the beverages. Signifi-
cant improvements in accuracy were reported, as mea-
sured by the rapid visual information processing test
(P = 0.011), when participants consumed the blackcur-
rant extract versus placebo, as well as improvements in
reaction time for some repetitions (1, 4 and 7) on the
digital vigilance task compared to baseline tests
Table 1 List of excluded studies
Study
reference Reason
Excluded after
abstract
reviewed
1 (66) No measure of cognition
2 (67) No measure of anthocyanin
in apples
3 (12) Animal study
4 (68) Not primary research
5 (69) Not primary research
6 (70) Animal study
7 (71) Conference abstract
8 (72) Animal study and nonfood based
9 (73) Conference abstract and study
design
10 (74) Review, not anthocyanin specific
11 (75) Conference abstract
12 (76) Editorial
13 (77) Review of blueberries, not focussed
on cognition
14 (78) Full text cannot be found
15 (79) Animal study
16 (80) Pomegranate extract in pill form
17 (81) Narrative review focussed on
animal studies (small section on
Krikorian papers identified)
18 (82) Animal study
19 (83) Review of grape products,
not focussed on cognition
20 (84) Review of animal studies
21 (85) Animal study
22 (86) Intervention not flavonoid related
23 (87) Review, cognitive outcomes
not addresses
24 (88) Review, not food vehicle
25 (89) Animal study, black soy contains
no anthocyanin
Excluded after
full text
retrieved
26 (57) No measure of anthocyanin in juice
27 (56) No measure of anthocyanin in juice
28 (58) No measure of anthocyanin in juice
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(P = 0.044) for blackcurrant juice or extract versus pla-
cebo. No change in mood or other tasks was recorded.
Whyte et al. (45) assessed dose-dependent change in
acute cognition after consumption of either 15 g or 30 g
of reconstituted freeze-dried blueberries in 21 children.
Consumption of a dose of 30 g (253 g of anthocyanin)
resulted in significant improvements in word recall after
five recall trials (P < 0.001) 95 min post-intervention for
a dose of 30 g versus control, as measured by the audi-
tory verbal learning test. Improved accuracy was reported
during a flanker interference task (response inhibition;
the ability to suppress responses that are inappropriate)
after 3 h, with respect to a dose of 30 g versus control
(P = 0.035). No improvement was seen for other tasks,
except for the go–no go task, in which the placebo condi-
tion was associated with significantly better results.
Whyte et al. (41) assessed acute change in cognition
after consumption of 200 g of fresh blueberries (143 mg
of anthocyanins) provided in a milk-based smoothie in
16 children. There was a significant improvement in the
delayed recall portion of the RAVLT task after consump-
tion of the blueberry smoothie, although no improve-
ments were seen for any other task.
Caldwell et al. (44) assessed dose-dependency related to
change in acute cognition after the consumption of either
a single 3000-mL serving of cherry juice (55 mg of antho-
cyanins) or three 100-mL servings at 0, 1 and 2 h. The
researchers compared younger and older adults, with and
without dementia. For the older adults only, a significant
improvement was seen for the task switching test at 6 h
compared to baseline (P = 0.03) (although this was
attributed to type 1 error) and no changes in acute cogni-
tion were reported for any of the other tests.
Discussion
The aim of this systematic review was to assess the effects
of anthocyanins consumed from food (not supplements)
on domains of cognitive function, as well as to highlight
gaps in the literature and address the applicability of the
available evidence for development of future study
designs. Despite more than a decade of preclinical evi-
dence supporting the association of anthocyanin intake
on cognitive outcomes (33), there remains a lack of exper-
imental studies conducted in humans. Six of the seven
studies included in the review reported positive benefits
of anthocyanin consumption on some aspect of cogni-
tion; however, the generalisability of the findings to other
clinical or healthy populations is limited by the small
study sample sizes and inconsistent methodologies. There
was a lack of homogeneity in the study designs that pre-
vented pooling of data for a quantitative analysis of the
magnitude of effect. From the available data, it is unclear
in which population the effects are most likely or which
doses of anthocyanins and/or their food sources are effec-
tive at inducing cognitive benefit.
The cognitive domains that appear to be acutely sensi-
tive to consumption of anthocyanin-rich foods are verbal
learning and memory, whereas, additionally, longer-term
consumption also impacts upon attention and working
memory. However, there is a lack of consensus regarding
the choice of best instruments and methods to employ in
studies that investigate potential change in cognitive func-
tion (36). The seven identified studies used a wide range
of tools to address multiple cognitive domains between
studies. This limitation has been recognised and evaluated
in a recent methodological review (46). That review con-
cluded that future studies should be guided by positive
findings from previous similar research, and that it may
be best to continue to include a battery of sensitive and
specific tools that address multiple cognitive domains,
until there is better understanding of specific brain func-
tions that are influenced by these bioactive components
in foods.
The duration of time needed to see an effect within
both acute and longer-term trials is also poorly under-
stood. The studies of Kent et al. (43) and Krikorian et al.
(39,40) suggest that cognitive benefits are seen after
12 weeks of intervention, and that extending the study
period to 16 weeks may not necessarily improve the
strength of the association (39). The timing related to the
acute impact of food-based anthocyanins on cognition is
hampered by the limited knowledge of whether the intact
anthocyanins or their metabolites, or both, are responsi-
ble for the beneficial effects of an anthocyanin-rich
diet (47). Two of the acute studies (41,42) included in this
review did not extend their trial times to encompass the
secondary uptake of anthocyanin-related metabolites in
the colon, and thus may have missed an important later
interaction that these compounds have on cognition. The
acute cross-over trial by Caldwell et al. (44) found no sig-
nificant change in cognition 6 h post-intervention but the
small numbers of participants suggest that it was likely to
be underpowered to observe cognitive effects.
Another outcome from this systematic literature review
is that biomarker data to confirm anthocyanin uptake in
the included studies were lacking. Only one study (42)
conducted an objective analysis of biological specimens to
determine the uptake and metabolism of the antho-
cyanins present in the intervention foods. Such funda-
mental data are needed to confirm the bioavailability of
anthocyanins from different foods and to determine
which of the bioactive components are specifically associ-
ated with the observed health benefits. There is growing
evidence to suggest that the biological activity of some
flavonoids may improve during metabolism, in
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comparison with their intact variants, which further com-
plicates the interpretation of their biological effects of
both the type and quantity found naturally in foods. In
addition to metabolic conjugation and methylation of
flavonoids in the human body, intestinal bacteria are
also considered to play an integral role in their metabo-
lism (48). Studies that investigate the health effects of
anthocyanins will need to consider new paradigms to
understand their bioactivity in vitro, in an attempt to
better explain their mechanisms of action (48). A recent
study (23) attempted to account for the fate of the
remaining 99% of ingested anthocyanins that are not
recovered in blood and urine. Rather than confirm that
anthocyanins had low bioavailability resulting from poor
absorption and chemical instability (48), the study identi-
fied an extensive biotransformation of anthocyanins that
resulted in a relative bioavailability (i.e. the amount
absorbed and found in blood, urine and breath) of 12%,
rather than the previously assumed 1%. An extensive
diversity of metabolites was identified (>30 unique struc-
tures), including phenolic, hippuric, phenylacetic and
phenylpropenoic acids. These findings have important
ramifications for future studies, in which urine and
plasma sampling periods in short-term bioavailability
studies should be extended because anthocyanin-derived
metabolites are still being excreted up to 48 h post-inges-
tion (22,23,25). As well as plasma/serum and urine, faeces
should also be collected as an integral sampling ‘matrix’
in future human research to measure the metabolites pro-
duced by the gut/colonic microbiota. This information
will be essential to further clarufy how dietary antho-
cyanins exert their biological activities in vivo.
In the case of the full complement of flavonoid
metabolites not being able to be measured, other charac-
teristic biomarkers of intake could be identified and
assessed (49). For example, one study measured change in
nonspecific measures of inflammation (43) as a potential
reflection of the anti-inflammatory mechanisms related to
flavonoid bioactivity, and reported no significant impact
on C-reative protein or interleukin-6 levels. However, the
various other mechanisms by which flavonoids are pur-
ported to provide neuroprotection and improve memory
and cognition (5,6) are not explained by anti-inflammatory
biomarkers, and thus this choice of biomarker may not
necessarily reflect the total bioactivities of flavonoids
in vivo.
Ageing is associated with changes in the functional
properties of the digestive system, such as delayed transit
time, losses in absorptive function and the influence of
prescription medication use on gut microbiota (50).
Therefore, the effect of age may influence the bioavailabil-
ity and metabolism of anthocyanins (50). This hypothesis
has not been adequately tested but should be a
consideration when comparing interventions across age
groups. The studies included in the present review inves-
tigated groups ranging in age from children (8–10 years)
to older adults (>68 years) with mild-cognitive impair-
ment and dementia. Disease states that affect brain func-
tion, including vascular and nonvascular dementia, as
well as Alzheimer’s disease, may also result in different
measureable outcomes in these groups (51), as shown by
the limited impact of antioxidant clinical trials in these
groups (51). It is therefore important to clearly define
patient groups and describe the differences in outcomes
between children, as well as healthy young and older
adults.
The vehicle for provision of anthocyanins also warrants
consideration. All of the studies in the review provided
anthocyanins in the form of a beverage, although the use
of this vehicle was not well explained. It can be specu-
lated that the provision of a preformulated juice is an
ideal way to control the variation of anthocyanins in the
fresh-fruit equivalent, which can be heavily influenced by
growth conditions and can differ between seasons. Provi-
sion of a juice also reduces the impact of fruit seasonality
on having sufficient fruit available year-round. The
impact of food processing can also substantially alter the
anthocyanin content of foods, especially with regard to
heating or cooking. For example, heating of dark antho-
cyanin-rich blood plums during jam making resulted
in losses of up to 70% of their total anthocyanin
content (52). Additionally, some studies administered rela-
tively large doses of anthocyanin-rich beverages (up to
over 600 mL), presumably to maximise the potential of
the bioactive anthocyanins. The division of the antho-
cyanin-rich food over three servings per day in the
longer-term trials (39,40) may have diminished their bioac-
tivity, where the provision of smaller doses may not have
provided a sufficient concentration of anthocyanin to
exert a physiological effect, compared to an increased
bioactivity if a larger serve is consumed at once. There is
a trade-off in clinical trial methodology between reflecting
the usual intake of anthocyanin-rich foods, as spread
throughout the day, and ensuring that a sufficiently high
dose is provided (in a single serving) to observe out-
comes. The dose–response mechanisms for the impact of
anthocyanin-rich food on cognition have not been well
investigated, and the differences in anthocyanin intake
across the intervention studies were vast. One study (44)
that provided a juice much lower in anthocyanin content
(18.6 mg/100 mL; 55 mg per serving) than the other tri-
als reported no acute cognitive benefits, and therefore this
dose may not be sufficiently high to induce acute cogni-
tive change. Future trials are needed to further clarify the
dose-dependent responses associated with the consump-
tion of anthocyanin-rich foods. Interestingly, the
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cognitive benefits associated with anthocyanin-rich food
consumption do not appear to be limited to one food,
with benefits documented after consuming blueberries,
blackberries and cherries.
Berries, particularly blueberries and blackberries, have
received the most interest in studies investigating the
health impacts of anthocyanin-rich foods. Many other
anthocyanin-rich sources have been overlooked, including
vegetables such as red onions and cabbage. The potential
for these foods to influence cognition needs to be con-
firmed because the large dependence in research on ber-
ries limits the translation of the outcomes to nutritional
advice for the population. The consumption of large
amounts of berries is not always feasible because berries
are often expensive, seasonal (not available year-round)
and can spoil quickly. The use of freeze-dried fruits to
overcome these barriers may be a possibility, providing
that the anthocyanin content of the fresh fruit equivalent
is not spoiled. Freeze-dried fruit may be a nutritionally
more preferable way in which to consume anthocyanins
compared to the encapsulated anthocyanins or antho-
cyanins added to other processed foods. This is because
anthocyanin pigments present within natural foods are
unlikely to be working independently because plants typi-
cally contain a complex mixture of flavonoids that have
synergistic bioactivities (53). Some studies have found that
anthocyanin bioactivity may be increased when they are
consumed within a mixture of polyphenols (e.g. as they
would naturally occur within a complex food matrix) (54).
This emphasises the importance of investigating whole food
sources of anthocyanins, rather than isolated and encapsu-
lated anthocyanins when studying health-related outcomes.
Background diet was considered by only one of the
intervention studies (45), where recommendations were
provided on which foods to avoid the evening prior to
testing day. Diet was controlled on the day of the inter-
vention in the longer acute trials (44,45) but was not con-
trolled in the longer-term trials. Controlling the
background diet, or at least monitoring it, is an impor-
tant consideration in flavonoid trials (49) with respect to
isolating the effect of the intervention. The provision of
low flavonoid and/or washout diets before and during tri-
als may be an effective way of reducing the impact of
habitual diet on intervention outcomes, although moni-
toring habitual diet throughout the period of longer-term
interventions may also be useful for identifying potential
dietary confounders (49). Alternatively, excluding potential
participants with abnormally high (vegans, vegetarians) or
low flavonoid intake may be an easier way of reducing
the influence of background diet on the study results (49).
The potential benefit of an anthocyanin intervention to
improve cognitive outcomes when the background diet of
an individual is already rich in dietary flavonoids and/or
anthocyanins needs to be considered in future research.
Ideally, an intervention would contain an anthocyanin
dosage that can feasibly be achieved in a habitual diet.
The ideal protocol for standardising the background diet
among participants, either by providing a controlled diet
or providing recommendations regarding the intake of
flavonoid rich foods, including the length of run-in peri-
ods in flavonoid trials, has not been investigated and
identified, although a minimum of 3 days has been sug-
gested (49). However, manipulation of the background
diet of participants limits the usefulness of the interven-
tion findings in a real world setting.
The implication of study design (i.e. a cross-over
design versus parallel groups) is important when consid-
ering flavonoid trials. As a result of the high inter-indivi-
dual variability in the metabolism of flavonoids (55), a
cross-over design where each individual serves as their
own control is arguably more appropriate, especially in
trials with small sample sizes. In these study designs,
however, the influence of learned practice effects on per-
formance in the cognitive tasks associated with repeated
testing would need to be accounted for.
Three studies were excluded on the basis of not having
a measure of anthocyanin content of the intervention
juice (56–58). Hendrickson et al. (58) measured total pheno-
lic content but did not report anthocyanin content
specifically. Previous research has shown that both
cranberry (59) and grape juice (39) contain anthocyanins
but, without an objective measure of their anthocyanin
content, the extent to which their bioactivity relates to
the anthocyanin content, specifically, cannot be specu-
lated. These studies showed that, in older adults (n = 5),
daily concord grape juice consumed (4–6 mL kg1 body
weight divided over three servings per day) over 12 weeks
was associated with significant improvements (P = 0.04)
in verbal learning and memory on the California Verbal
Learning Test (56). In young adults (n = 35), grape juice
(10 mL kg1 body weight) had no impact on acute cog-
nition (58) (implicit memory as measured by a word frag-
ment completion task) and cranberry juice consumption
(470 mL consumed twice per day) had no significant
impact on cognitive outcomes (57).
Lastly, it is important to note here the distinction
between the terms anthocyanins and anthocyanidins,
which are sometimes used interchangeably but incorrectly
in the literature. Anthocyanins are glycosylated antho-
cyanidins (aglycones), which are the naturally occurring
water-soluble pigments in coloured fruits and vegetables,
whereas anthocyanidins are rarely found in nature
because of their poor stability (18,19) and differ in terms
of molecular size and polarity (18). Anthocyanins are more
water soluble, whereas anthocyanidins are more
hydrophobic (18,19). Anthocyanidins are the initial
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degradation products in the gut microbial metabolism of
anthocyanins, which can be transported to the colon as
matrix-bound glycosides (60). After hydrolysis by micro-
biota, the released and unstable aglycones are rapidly
degraded to their respective phenolic acids depending on
their aglycone structure (e.g. cyanidin to protocatechuic
acid, malvidin to syringic acid and peonidin to vanillic
acid) (60). There are contradicting reports in the litera-
ture about the (bio)activity of anthocyanins and
anthocyanidins. Tsuda et al. (61) measured a stronger
in vitro antioxidative activity of cyanidin (anthocyanidin)
than cyanidin-3-glucoside (anthocyanin) in an experi-
mental liposome/rabbit erythrocyte membrane model.
However, a similar in vitro radical scavenging activity was
reported for eight common anthocyanidins and seven
anthocyanins (62), whereas a weaker inhibitory effect on
cell transformation could be observed for delphinidin
glycosides (anthocyanins) compared to their sugar-
free aglycone delphinidin (anthocyanidin) (63). However,
it is unlikely that intact (non-metabolised) anthocyani-
dins exert any significant biological effects because
of their instability at neutral and physiological pH
conditions (64,65).
In conclusion, the impact of food-based anthocyanin
consumption on both acute and long-term cognition
appears to be promising, with six of seven studies reporting
improvements in either single, or multiple, cognitive out-
comes after anthocyanin-rich food consumption. However,
adequately powered studies that utilise sensitive cognitive
tasks previously shown to detect changes in cognition in
anthocyanin trials (e.g. the RAVLT for measuring change
in verbal learning and memory) are needed to confirm
these findings. Future research should focus on follow cur-
rent recommendations for designing, implementing and
reporting of flavonoid trials (49). Studies should focus on
clarifying which sources of anthocyanin-rich foods are
most beneficial and the dosage of anthocyanin intake
needed to induce acute and longer-term cognitive effects.
Ultimately, this will allow statistical comparison between
studies, and potentially lead to the translation of research
into dietary messages about dietary anthocyanins for acute
and longer-term cognitive benefits.
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